FDA Advises Caution, Consultation Before Using 99.99% Germ-Killing Claims On Sanitizers
Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.
You may also be interested in...
Personal Care Products In Court: Clinique May Settle Probiotic Suit; ‘99.99% Of Germs’ Sanitizer Update
The latest on proposed false-advertising class actions targeting Clinique Laboratories for probiotic representations and leading hand sanitizer manufacturers for “kills 99.99% of germs” claims.
Bausch Health says its Lumify OTC redness reliever drops showed "complete inactivation" of COVID-19 in time-kill tests, with preservative compound benzalkonium chloride apparently the key reason. The in vitro findings prompted it to consider discussions with regulatory agencies on proposing a remedy for the virus.
The US FDA has primary jurisdiction over labeling claims on OTC consumer antiseptic rubs, and state false advertising claims lodged by the plaintiff are preempted by federal law, Edgewell Personal Care argues in its motion to dismiss a proposed class action in California federal court regarding Wet Ones germ-killing claims.